News Focus
News Focus
Followers 36
Posts 2259
Boards Moderated 0
Alias Born 10/18/2019

Re: iwasadiver post# 477092

Saturday, 05/21/2022 11:54:22 PM

Saturday, May 21, 2022 11:54:22 PM

Post# of 827908
Diver, I believe UCLA did a phase 1 trial with 23 (?) Or so patients before the product was liscenced to nwbo. The 2011 paper by Prins Liau and others I believe was based on this ucla study on genetic subgroups and later paper on til overlap. Far more than 2 patients
Mrk is a giant with all sorts of ongoing research and provide keytruda for many studies not sponsored by mrk.
Most of us want this combo trial to become a major item but we come from a different perspective, imo much as I would like to think merck wants to buy nwbo it may be just another bit of research mrk contributes to by giving keytruda for free
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News